News tagged with adverse cardiovascular events

Results from the BIONICS trial reported

The large multinational randomized BIONICS study found that a novel ridaforolimus-eluting stent (BioNIR) was non-inferior to a zotarolimus-eluting stent (Resolute) for one-year clinical outcomes in a broad, less selected ...

Oct 31, 2016
popularity0 comments 0

Subscribe to rss feed